74003-5

LOINC 2.82

CYP3A4 gene c.-392A>G (*1B) [Presence] in Blood or Tissue by Molecular genetics method

CYP3A4 c.-392A>G (*1B) Bld/T Ql

Definition

  • CYP3A4 gene mutation analysis for targeted variant CYP3A4*1B is performed to determine a patient's allellic genotype. The resulted genotype is used to predict overall drug metabolism phenotype (ultrarapid, extenisive, intermediate, or poor metabolizer).

Component

  • CYP3A4 gene.c.-392A>G (*1B)

Specimen / system

  • Bld/Tiss

Class

  • MOLPATH.PHARMG

Property

  • PrThr

Scale

  • Ord

Method

  • Molgen

Related names

  • Blood; CP33; CP34; CYP3A; CYP3A3; CYP3A4 c.-392A>G (*1B); CYPIIIA3; CYPIIIA4; cytochrome P450, family 3, subfamily A, polypeptide 4; Genetics; Heredity; Heritable; HLP; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.PHARMG; NF-25; Ordinal; P450C3; P450PCN1; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue

Index terms

  • Blood
  • CP33
  • CP34
  • CYP3A
  • CYP3A3
  • CYP3A4 c.-392A&gt
  • CYP3A4 gene.c.-392A>G (*1B)
  • CYPIIIA3
  • CYPIIIA4
  • cytochrome P450, family 3, subfamily A, polypeptide 4
  • G (*1B)
  • Genetics
  • Heredity
  • Heritable
  • HLP
  • Inherited
  • Molecular genetics
  • Molecular pathology
  • MOLPATH
  • MOLPATH.PHARMG
  • NF-25
  • Ordinal
  • P450C3
  • P450PCN1
  • PCR
  • Point in time
  • PR
  • QL
  • Qual
  • Qualitative
  • Random
  • Screen
  • Tissue
  • Tissue, unspecified
  • WB
  • Whole blood
  • Whole blood or Tissue